WisdomTree BioRevolution Fund (WDNA) is an ETF managed by WisdomTree. Its largest position is Moderna, Inc. (MRNA), representing 4.54% of fund assets.
WisdomTree BioRevolution Fund Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- WDNA
- Type:
- ETF
- Manager:
- WisdomTree
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- Jun 1, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
Moderna, Inc.
|
4.54% | $102,819.20 | 2,024 |
|
-
JOHNSON & JOHNSON
|
3.15% | $71,376.48 | 292 |
|
-
UNITED THERAPEUTICS Corp
|
2.80% | $63,448.86 | 107 |
|
-
PFIZER INC
|
2.74% | $62,000.64 | 2,208 |
|
-
ELI LILLY & Co
|
2.64% | $59,785.05 | 65 |
|
-
Stoke Therapeutics, Inc.
|
2.53% | $57,273.04 | 1,759 |
|
-
Natera, Inc.
|
2.53% | $57,197.14 | 286 |
|
-
AMGEN INC
|
2.35% | $53,129.35 | 151 |
|
-
Twist Bioscience Corp
|
2.32% | $52,414.56 | 1,103 |
|
-
ASTRAZENECA PLC
|
2.28% | $51,671.64 | 262 |
|
-
Structure Therapeutics Inc.
|
2.20% | $49,838.80 | 1,034 |
|
-
AMICUS THERAPEUTICS INC
|
2.19% | $49,670.10 | 3,435 |
|
-
BioNTech SE
|
2.09% | $47,373.04 | 533 |
|
-
IONIS PHARMACEUTICALS INC
|
2.06% | $46,630.89 | 621 |
|
-
GILEAD SCIENCES, INC.
|
1.96% | $44,319.66 | 318 |
|
-
CRISPR Therapeutics AG
|
1.87% | $42,384.87 | 891 |
|
-
Immunome Inc.
|
1.86% | $42,165.36 | 1,928 |
|
-
APPLIED MATERIALS INC /DE
|
1.85% | $41,933.81 | 711 |
|
-
Beam Therapeutics Inc.
|
1.82% | $41,130.58 | 1,726 |
|
-
10x Genomics, Inc.
|
1.78% | $40,337.00 | 1,900 |
|
-
DARLING INGREDIENTS INC.
|
1.70% | $38,470.70 | 622 |
|
-
APPLIED MATERIALS INC /DE
|
1.65% | $37,301.08 | 248 |
|
-
Roivant Sciences Ltd.
|
1.60% | $36,203.90 | 1,307 |
|
-
Krystal Biotech, Inc.
|
1.57% | $35,648.16 | 138 |
|
-
AGIOS PHARMACEUTICALS, INC.
|
1.57% | $35,453.84 | 1,048 |
|
-
Bunge Global SA
|
1.54% | $34,852.80 | 274 |
|
-
APPLIED MATERIALS INC /DE
|
1.49% | $33,644.88 | 945 |
|
-
Intellia Therapeutics, Inc.
|
1.48% | $33,614.04 | 2,622 |
|
-
Corteva, Inc.
|
1.45% | $32,814.32 | 392 |
|
-
ARROWHEAD PHARMACEUTICALS, INC.
|
1.43% | $32,415.90 | 517 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
1.36% | $30,811.26 | 69 |
|
-
REGENXBIO Inc.
|
1.32% | $29,933.36 | 3,572 |
|
-
ARCELLX INC
|
1.28% | $28,934.64 | 252 |
|
-
Allogene Therapeutics, Inc.
|
1.25% | $28,240.56 | 11,574 |
|
-
BRISTOL MYERS SQUIBB CO
|
1.20% | $27,110.55 | 447 |
|
-
APPLIED MATERIALS INC /DE
|
1.17% | $26,417.05 | 742 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
1.13% | $25,497.12 | 33 |
|
-
GENMAB A/S
|
1.10% | $24,978.73 | 931 |
|
-
VERBIO SE
|
1.05% | $23,694.07 | 449 |
|
-
BIOMARIN PHARMACEUTICAL INC
|
1.02% | $23,160.90 | 410 |
|
-
APPLIED MATERIALS INC /DE
|
1.01% | $22,961.97 | 506 |
|
-
ARGENX SE
|
0.94% | $21,177.25 | 29 |
|
-
Viking Therapeutics, Inc.
|
0.91% | $20,695.44 | 636 |
|
-
VERACYTE, INC.
|
0.91% | $20,517.77 | 637 |
|
-
Editas Medicine, Inc.
|
0.89% | $20,209.54 | 8,182 |
|
-
DANAHER CORP /DE/
|
0.89% | $20,097.60 | 106 |
|
-
Arcturus Therapeutics Holdings Inc.
|
0.85% | $19,253.68 | 2,494 |
|
-
Absci Corp
|
0.84% | $18,957.00 | 6,319 |
|
-
IOVANCE BIOTHERAPEUTICS, INC.
|
0.82% | $18,508.23 | 5,273 |
|
-
Tempus AI, Inc.
|
0.78% | $17,635.80 | 390 |
Advertisement (320x50)